Literature DB >> 25164326

Scoring of chest CT in children with cystic fibrosis: state of the art.

Alistair D Calder1, Andrew Bush, Alan S Brody, Catherine M Owens.   

Abstract

Chest CT has been proposed as a surrogate outcome measure in the evaluation of cystic fibrosis lung disease. Quantitative evaluation of chest CT findings requires application of a scoring system to derive numerical values. Several scoring systems are in use. These mostly rely on a subjective judgement of the severity and extent of various features of cystic fibrosis lung disease, including bronchiectasis, bronchial wall thickening, mucous plugging and air-trapping. Scores can subsequently be added to produce a total score. The precision or reproducibility of scoring systems has been assessed but with heterogeneous statistical approaches. Total scores appear to have high levels of reproducibility, but this might mask poorer levels of agreement for individual observations and component scores. It can also be questioned whether total scores are biologically meaningful, as compared to assessments of individual features. Various studies suggest that CT scores give an accurate indicator of the severity of disease, and CT scores might be the best predictors of long-term outcome, but data in this area are limited. CT scores are more sensitive than traditional lung-function indices such as FEV; however the lung clearance index, by multiple breath washout, appears to offer comparable sensitivity to CT. It is not clear whether CT scores are adequately responsive to changes in disease severity in the short to medium term; this is a challenge to the use of CT as a surrogate outcome measure for clinical trials of therapies specific to cystic fibrosis. Cystic fibrosis scoring would benefit from greater levels of standardisation in terms of CT techniques, scoring system, training of observers and measures of reproducibility. Automated approaches to quantifying CT parameters might also offer improved precision. The benefits of chest CT must be weighed against the principal drawback of radiation exposure. The case for more widespread use of chest CT would be strengthened if precision of CT scoring were improved.

Entities:  

Mesh:

Year:  2014        PMID: 25164326     DOI: 10.1007/s00247-013-2867-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  58 in total

1.  High resolution CT in children with cystic fibrosis: correlation with pulmonary functions and radiographic scores.

Authors:  F B Demirkazik; O M Ariyürek; U Ozçelik; A Göçmen; H K Hassanabad; N Kiper
Journal:  Eur J Radiol       Date:  2001-01       Impact factor: 3.528

2.  An automated approach to quantitative air trapping measurements in mild cystic fibrosis.

Authors:  Michael L Goris; Hongyun J Zhu; Francis Blankenberg; Frandics Chan; Terry E Robinson
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

3.  Bronchoarterial ratio and bronchial wall thickness on high-resolution CT in asymptomatic subjects: correlation with age and smoking.

Authors:  Shin Matsuoka; Katsuhiro Uchiyama; Hideki Shima; Naoyuki Ueno; Sonomi Oish; Yoko Nojiri
Journal:  AJR Am J Roentgenol       Date:  2003-02       Impact factor: 3.959

Review 4.  Biomarkers and surrogate end points--the challenge of statistical validation.

Authors:  Marc Buyse; Daniel J Sargent; Axel Grothey; Alastair Matheson; Aimery de Gramont
Journal:  Nat Rev Clin Oncol       Date:  2010-04-06       Impact factor: 66.675

5.  Bronchial measurement with three-dimensional quantitative thin-section CT in patients with cystic fibrosis.

Authors:  Michel Montaudon; Patrick Berger; Agathe Cangini-Sacher; Gabriel de Dietrich; José Manuel Tunon-de-Lara; Roger Marthan; François Laurent
Journal:  Radiology       Date:  2006-12-19       Impact factor: 11.105

6.  Assessment of early bronchiectasis in young children with cystic fibrosis is dependent on lung volume.

Authors:  Lauren S Mott; Karla G Graniel; Judy Park; Nicholas H de Klerk; Peter D Sly; Conor P Murray; Harm A W M Tiddens; Stephen M Stick
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

7.  The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease.

Authors:  Samya Z Nasr; Ermelinda Sakmar; Emmanuel Christodoulou; Boris P Eckhardt; Daniel S Streetman; Peter J Strouse
Journal:  Pediatr Pulmonol       Date:  2010-05

8.  High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate.

Authors:  A S Brody; P L Molina; J S Klein; B S Rothman; M Ramagopal; D R Swartz
Journal:  Pediatr Radiol       Date:  1999-10

9.  Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening.

Authors:  Peter D Sly; Siobhain Brennan; Catherine Gangell; Nicholas de Klerk; Conor Murray; Lauren Mott; Stephen M Stick; Philip J Robinson; Colin F Robertson; Sarath C Ranganathan
Journal:  Am J Respir Crit Care Med       Date:  2009-04-16       Impact factor: 21.405

Review 10.  Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease.

Authors:  Terry E Robinson
Journal:  Proc Am Thorac Soc       Date:  2007-08-01
View more
  16 in total

1.  Influence of radiation dose and reconstruction algorithm in MDCT assessment of airway wall thickness: A phantom study.

Authors:  Daniel Gomez-Cardona; Scott K Nagle; Ke Li; Terry E Robinson; Guang-Hong Chen
Journal:  Med Phys       Date:  2015-10       Impact factor: 4.071

2.  Structural and perfusion magnetic resonance imaging of the lung in cystic fibrosis.

Authors:  Christina Amaxopoulou; Ralph Gnannt; Kai Higashigaito; Andreas Jung; Christian J Kellenberger
Journal:  Pediatr Radiol       Date:  2017-11-15

3.  Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group.

Authors:  Katharina Schütz; Diana Alecsandru; Bodo Grimbacher; Jamanda Haddock; Annemarie Bruining; Gertjan Driessen; Esther de Vries; Peter M van Hagen; Ieneke Hartmann; Francesco Fraioli; Cinzia Milito; Milica Mitrevski; Isabella Quinti; Goffredo Serra; Peter Kelleher; Michael Loebinger; Jiri Litzman; Vera Postranecka; Vojtech Thon; Judith Babar; Alison M Condliffe; Andrew Exley; Dinakantha Kumararatne; Nick Screaton; Alison Jones; Maria P Bondioni; Vassilios Lougaris; Alessandro Plebani; Annarosa Soresina; Cesare Sirignano; Giuseppe Spadaro; Nermeen Galal; Luis I Gonzalez-Granado; Sabine Dettmer; Robert Stirling; Helen Chapel; Mary Lucas; Smita Patel; Claire-Michele Farber; Isabelle Meyts; Arpan K Banerjee; Scott Hackett; John R Hurst; Klaus Warnatz; Benjamin Gathmann; Ulrich Baumann
Journal:  J Clin Immunol       Date:  2018-12-13       Impact factor: 8.317

4.  Chest computed tomography predicts the frequency of pulmonary exacerbations in children with cystic fibrosis.

Authors:  Don B Sanders; Zhanhai Li; Alan S Brody
Journal:  Ann Am Thorac Soc       Date:  2015-01

5.  Quantification of Cystic Fibrosis Lung Disease with Radiomics-based CT Scores.

Authors:  Guillaume Chassagnon; Evangelia I Zacharaki; Sébastien Bommart; Pierre-Régis Burgel; Raphael Chiron; Séverine Dangeard; Nikos Paragios; Clémence Martin; Marie-Pierre Revel
Journal:  Radiol Cardiothorac Imaging       Date:  2020-12-17

6.  An automated computed tomography score for the cystic fibrosis lung.

Authors:  Guillaume Chassagnon; Clémence Martin; Pierre-Régis Burgel; Dominique Hubert; Isabelle Fajac; Nikos Paragios; Evangelia I Zacharaki; Paul Legmann; Joel Coste; Marie-Pierre Revel
Journal:  Eur Radiol       Date:  2018-06-04       Impact factor: 5.315

7.  Quantitative chest computerized tomography and FEV1 equally identify pulmonary exacerbation risk in children with cystic fibrosis.

Authors:  Don B Sanders; Zhanhai Li; Katelyn Parker-McGill; Philip Farrell; Alan S Brody
Journal:  Pediatr Pulmonol       Date:  2018-08-29

8.  Changes in mucociliary clearance over time in children with cystic fibrosis.

Authors:  Beth L Laube; Kathryn A Carson; Christopher M Evans; Vanessa L Richardson; Gail Sharpless; Pamela L Zeitlin; Peter J Mogayzel
Journal:  Pediatr Pulmonol       Date:  2020-05-29

9.  Sensitive structural and functional measurements and 1-year pulmonary outcomes in pediatric cystic fibrosis.

Authors:  Matthew M Willmering; David J Roach; Elizabeth L Kramer; Laura L Walkup; Zackary I Cleveland; Jason C Woods
Journal:  J Cyst Fibros       Date:  2020-12-04       Impact factor: 5.482

10.  Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports.

Authors:  Mônica Cássia Firmida; Elizabeth Andrade Marques; Robson Souza Leão; Rosana Helena Vicente Pereira; Elenice Rosa Aguiar Rodrigues; Rodolpho Mattos Albano; Tania Wrobel Folescu; Vagner Bernardo; Pedro Daltro; Domenico Capone; Agnaldo José Lopes
Journal:  Respir Med Case Rep       Date:  2017-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.